EC Gynaecology

Introduction: Metabolic syndrome refers to a condition, which includes particular risk factors that are specific for cardiovascular diseases. This research critically examines the prevalence of metabolic syndrome in patients with polycystic ovarian syndrome attending the DAHC in Dubai, UAE.

Methods: The study was conducted as a retrospective cross-sectional study at the Primary health facility in Dubai Academic Health Corporation (DAHC). The metabolic syndrome of participants of the study is analysed in terms of five factors. They are BMI over 30, blood pressure, HDL, Triglyceride, and Blood sugar level. The sample size of the study included 267 female patients.

Results: The results revealed that 12.5% of participants are there with the three factors. 10 females included in the study have 4 factors out of 5, which is only 3.8% of the sample. However, there is only one female with all five factors within the cluster of metabolic syndrome which is insignificant in percentage as it is only 0.4%.

Discussion: The results of the present study have several differences when compared to the studies conducted by other researchers. A potential reason can be due to the use of different measures in the present study.

Conclusion: It is concluded that the prevalence of metabolic syndrome in patients with PCOS in the UAE is identified as only 16.7% which is lower than the studies conducted in other countries about PCOS women with metabolic syndrome. It is recommended that future research should conduct the study with a large sample size to find the deviations in the findings.

 Keywords: Metabolic Syndrome; Polycystic Ovarian Syndrome (PCOS); Blood Pressure; HDL; BMI; Blood Sugar Level; Triglyceride

1. Ali AT., et al. “Polycystic ovary syndrome and metabolic disorders: A review of the literature”. African Journal of Reproductive Health8 (2022): 89-99.
2. Khorshidi A., et al. “The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: a systematic review and meta-analysis”. Diabetes and Metabolic Syndrome: Clinical Research and Reviews4 (2019): 2747-2753.
3. World Health Organization [Internet]. Polycystic ovary syndrome (2023).
4. Juber NF., et al. “Association between self-reported polycystic ovary syndrome with chronic diseases among emiratis: a cross-sectional analysis from the UAE healthy future study”. International Journal of Women's Health 15 (2023): 289-298.
5. Essah PA and Nestler JE. “Metabolic syndrome in women with polycystic ovary syndrome”. Fertility and Sterility1 (2006): S18-S19.
6. National Cholesterol Education Program (NCEP): Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. “Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report”. Circulation 25 (2002): 3143-3421.
7. Obeidat AA., et al. “Alarming high prevalence of metabolic syndrome among Jordanian adults”. Pakistan Journal of Medical Sciences6 (2015): 1377-1382.
8. Li R., et al. “Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross-sectional study”. BMC Endocrine Disorders1 (2014): 76.
9. Dargham SR., et al. “The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population”. PloS one7 (2017): e0181467.
10. Lee I., et al. “Higher incidence of metabolic syndrome in Black women with polycystic ovary syndrome: a longitudinal study”. The Journal of Clinical Endocrinology and Metabolism4 (2022): e1558-e1567.
11. Zahiri Z., et al. “Metabolic syndrome in patients with polycystic ovary syndrome in Iran”. International Journal of Fertility and Sterility4 (2016): 490-496.